Recent studies implicate dysregulated innate immune signaling in MDS, including overexpression of TLRs, IL-8 and its receptor CXCR2, and IL-1 downstream effector signaling pathways (Figure 1) [11,12,29]. The gene discussed is CXCL8; the disease is myelodysplastic syndrome.